-
Reading a Framycetin Sulfate Certificate of Analysis: What 759 IU/mg Actually Tells You
Oct , 10 2026
Our current commercial batch of Framycetin Sulfate API measured 759 IU/mg against a Ph. Eur. minimum of 630 IU/mg — about 20% headroom — with pH 6.3, specific optical rotation +52.6°, loss on drying 6...
read more
-
Framycetin Sulfate vs Neomycin Sulfate: What API Buyers Need to Check Before Ordering
Oct , 10 2026
Framycetin sulfate (CAS 4146-30-9) is the sulfate salt of neomycin B — a purified single-entity aminoglycoside, distinct from the variable neomycin B/C/neamine mixture sold as neomycin sulfate (CAS 14...
read more
-
One Molecule, Two Precursors: What Makes Citicoline Sodium Stand Out
Sep , 17 2026
When choosing a brain-health ingredient, there's a rather practical problem: most products follow a "replace whatever is missing" logic — if you want choline, they give you only choline; if you want b...
read more
-
From Glucose Control to Liver Care: Semaglutide Becomes China's First GLP-1 Approved for MASH
Sep , 10 2026
A Boundary Crossed: GLP-1 Enters Hepatology On 10 September, China's National Medical Products Administration (NMPA) approved semaglutide injection (Wegovy®) for metabolic dysfunctio...
read more
-
Spilanthol (Acmella Oleracea Extract) | Natural Botox Alternative for Anti-Wrinkle Cosmetics
Aug , 18 2026
Spilanthol: The Gold Standard in Natural Expression-Line Relaxants (Botox-like Smoothing Without the Needle) Tired of synthetic peptides that under-deliver? Spilanthol, the signature alkylamide from A...
read more
-
Orforglipron vs. Semaglutide vs. Tirzepatide: The Ultimate 2026 Weight Loss Drug Comparison
May , 21 2026
1. Introduction: The GLP-1 Evolution The weight loss pharmaceutical market has dramatically shifted with the 2026 FDA approval of Orforglipron (Foundayo). This new oral, non-peptide agonist challenges...
read more
-
Market Insight: ECO 2026 Highlights Orforglipron's Potential to Reshape the $100B Oral GLP-1 Market
May , 19 2026
The European Congress on Obesity (ECO 2026) has concluded, but the excitement surrounding Orforglipron (LY3502970) continues to reverberate throughout the global pharmaceutical industry. For millions ...
read more
-
Beyond the Salt Form: How SINOWAY's Copper TriPeptide-1 (Copper Peptide/GHK-Cu) Enables Next-Generation Formulations
Apr , 14 2026
The choice between Copper Tripeptide-1 (Copper Peptide/ GHK-Cu/ CAS No.: 89030-95-5) hydrochloride and acetate is a critical formulation decision. However, the ultimate success of a product depends no...
read more
-
How to Choose: Copper Peptide (GHK-Cu) – Hydrochloride or Acetate?
Apr , 14 2026
Copper Tripeptide-1 (Copper Peptide/ GHK-Cu/ CAS No.: 89030-95-5) is a bioactive complex of the glycyl-histidyl-lysine tripeptide and a copper ion. The fundamental distinction between its hydrochlorid...
read more
IPv6 network supported
English
中文
français
Deutsch
русский
español
português
العربية
日本語
한국의
Türkçe
